Abstract
Streptococcus agalactiae is a highly invasive pathogen causing streptococcosis in aquaculture, globally. The potential use of lytic bacteriophage is considered as safe antimicrobials against the milieu of global antibiotic resistance in treating bacterial infections. Hence, in this study, a novel bacteriophage, Streptococcus phage-1A was isolated from infected tilapia farm against S. agalactiae. In the morphometric analysis by HR-TEM, Streptococcus phage-1A exhibited an isometric head (101.52 ± 2 nm) and short contractile tail (62.60 ± 1 nm), of the family Myoviridae. The phage has a short latent period (20 min) and high burst size of about 119 PFU/cell. PCR-based screening revealed its obligate lytic nature and could reveal the genomic diversity of the phage by RAPD. The phage was found to be stable at varying range of temperature, pH, and salinity. Protective efficiency of phage-1A was evaluated against S. agalactiae by challenge experiment in tilapia by 3 modes of application viz. IP, oral, and bath treatments. During the challenge experiment, it was found that there was a significant decrease in the count of S. agalactiae in phage treated fish organs compared to that of controls. Among the treatment trials, bath therapy was found to be more effective with 80.01% RPS comparing to IP (70.02%) and oral (50.04%) mode of administration. This is the first report on isolation, characterization, and application of bacteriophage against S. agalactiae from India and the Streptococcus phage-1A isolated in this study could demonstrate its high protective ability against streptococcal infection in tilapia.
Highlights
-
Streptococcus phage-1A, a specific lytic Myoviridae phage was isolated from tilapia aquaculture farm against Streptococcus agalactiae and it showed high burst size and high productivity at an MOI of 0.01.
-
Viability under different temperature and stability at different pH and salinity showed its efficiency in the elimination of Streptococcus agalactiae at each parameter.
-
Phage therapy against Streptococcus agalactiae challenged tilapia by bath therapy was found effective with 80.01% RPS comparing to other mode of application such as intra peritoneal injection (70.02%) and orally through phage-coated feed (50.04%).
-
The present study suggests bath therapy as a best mode of application of Streptococcus phage-1A in treating Streptococcus agalactiae infection in tilapia.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Ababouch L, Ababouch L, Gandini G, Ryder J, Gandini G, Ryder J (2005) Causes of detentions and rejections in international fish trade. Food and Agriculture Organization of the United Nations, Rome., FAO fisheries technical paper
Abu-Elala NM, Abd-Elsalam RM, Younis NA (2020) Streptococcosis, Lactococcosis and Enterococcosis are potential threats facing cultured Nile tilapia (Oreochromis niloticus) production. Aquac Res 51:4183–4195. https://doi.org/10.1111/are.14760
Adams MH (1959) Bacteriophages. Interscience Publishers, New York, USA
Adriaenssens E, Brister JR (2017) How to name and classify your phage: an informal guide. Viruses 9:E70. https://doi.org/10.3390/v9040070
Balding C, Bromley SA, Pickup RW, Saunders JR (2005) Diversity of phage integrases in Enterobacteriaceae: development of markers for environmental analysis of temperate phages. Environ Microbiol 7:1558–1567. https://doi.org/10.1111/j.1462-2920.2005.00845.x
Carroll-Portillo A, Lin HC (2019) Bacteriophage and the innate immune system: access and Signaling. Microorganisms 7:E625. https://doi.org/10.3390/microorganisms7120625
Chen CY, Bowser PR, Chao CB (2007) Comparative histopathology of Streptococcus iniae and Streptococcus agalactiae-infected tilapia. Eur Assoc Fish Pathol 27:2–9
Christiansen RH, Dalsgaard I, Middelboe M, Lauritsen AH, Madsen L (2014) Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture. Appl Environ Microbiol 80:7683–7693. https://doi.org/10.1128/AEM.02386-14
Donati VL, Dalsgaard I, Sundell K, Castillo D, Er-Rafik M, Clark J, Wiklund T, Middelboe M, Madsen L (2021) Phage-mediated control of Flavobacterium psychrophilum in aquaculture: in vivo experiments to compare delivery methods. Front Microbiol 12:628309. https://doi.org/10.3389/fmicb.2021.628309
FAO (2020) The State of World Fisheries and Aquaculture 2020. Sustainability in action. Rome, Italy
Friedman DI, Olson ER, Georgopoulos C, Tilly K, Hershowitz I, Banuett F (1984) Interactions of bacteriophage and host macromolecules in the growth of bacteriohpage λ. Microbiol Rev 48:299–325
Gutierrez D, Martin-Platero AM, Rodriguez A, Martinez-Bueno M, Garcia P, Martinez B (2011) Typing of bacteriophages by randomly amplified polymorphic DNA (RAPD)-PCR to assess genetic diversity: bacteriophage typing by RAPD-PCR. FEMS Microbiol Lett 322:90–97. https://doi.org/10.1111/j.1574-6968.2011.02342.x
Hardie JM, Whiley RA (1997) Classification and overview of the genera Streptococcus and Enterococcus. J App Microbiol 83:1–11. https://doi.org/10.1046/j.1365-2672.83.s1.1.x
Hernandez E, Figueroa J, Iregui C (2009) Streptococcosis on a red tilapia, Oreochromis sp., farm: a case study. J Fish Dis 32:247–252. https://doi.org/10.1111/j.1365-2761.2008.00981.x
Kalatzis PG, Bastías R, Kokkari C, Katharios P (2016) Isolation and characterization of two lytic bacteriophages, φSt2 and φGrn1; phage therapy application for biological control of Vibrio alginolyticus in aquaculture live feeds. PLoS ONE 11:e0151101. https://doi.org/10.1371/journal.pone.0151101
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. https://doi.org/10.1038/227680a0
Luo X, Liao G, Liu C, Jiang X, Lin M, Zhao C, Tao J, Huang Z (2018) Characterization of bacteriophage HN48 and its protective effects in Nile tilapia Oreochromis niloticus against Streptococcus agalactiae infections. J Fish Dis 4:1477–1484. https://doi.org/10.1111/jfd.12838
Manyi-Loh C, Mamphweli S, Meyer E, Okoh A (2018) Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules 23:795. https://doi.org/10.3390/molecules23040795
Matsuoka S, Hashizume T, Kanzaki H, Iwamoto E, Se Chang P, Yoshida T, Nakai T (2007) Phage therapy against β-hemolytic Streptococcicosis of Japanese flounder Paralichthys olivaceus. Fish Pathol 42:181–189. https://doi.org/10.3147/jsfp.42.181
Nakai T, Sugimoto R, Park K, Matsuoka S, Mori K, Nishioka T, Maruyama K (1999) Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis Aquat Org 37:33–41. https://doi.org/10.3354/dao037033
Nguyen S, Baker K, Padman BS, Patwa R, Dunstan RA, Weston TA, Schlosser K, Bailey B, Lithgow T, Lazarou M, Luque A, Rohwer F, Blumberg RS, Barr JJ (2017) Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mbio 8:e01874-17. https://doi.org/10.1128/mBio.01874-17
Oliveira J, Castilho F, Cunha A, Pereira MJ (2012) Bacteriophage therapy as a bacterial control strategy in aquaculture. Aquac Int 20(5):879–910. https://doi.org/10.1007/s10499-012-9515-7
Opperman CJ, Wojno JM, Brink AJ (2022) Treating bacterial infections with bacteriophages in the 21st century. South Afr J Infect Dis 37https://doi.org/10.4102/sajid.v37i1.346
Osman KM, Al-Maary KS, Mubarak AS, Dawoud TM, Moussa IMI, Ibrahim MDS, Hessain AM, Orabi A, Fawzy NM (2017) Characterization and susceptibility of Streptococci and Enterococci isolated from Nile tilapia (Oreochromis niloticus) showing septicaemia in aquaculture and wild sites in Egypt. BMC Vet Res 13:357. https://doi.org/10.1186/s12917-017-1289-8
Pallavi B, Puneeth TG, Shekar M, Girisha SK (2021) Isolation, characterization and genomic analysis of vB-AhyM-AP1, a lytic bacteriophage infecting Aeromonas hydrophila. J Appl Microbiol 131:695–705. https://doi.org/10.1111/jam.14997
Park S, Nakai T (2003) Bacteriophage control of Pseudomonas plecoglossicida infection in ayu, Plectoglossis altivelis. Dis Aquat Org 53:33–39. https://doi.org/10.3354/dao053033
Phumkhachorn P, Rattanachaikunsopon P (2010) Isolation and partial characterization of a bacteriophage infecting the shrimp pathogen Vibrio harveyi. Afr J Microbiol Res 4:1794–1800
Phuoc NN, Linh NTH, Crestani C, Zadoks RN (2021) Effect of strain and enviromental conditions on the virulence of Streptococcus agalactiae (Group B Streptococcus; GBS) in red tilapia (Oreochromis sp). Aquac 534:736256. https://doi.org/10.1016/j.aquaculture.2020.736256
Popescu M, Van Belleghem JD, Khosravi A, Bollyky PL (2021) Bacteriophages and the immune system. Annu Rev Virol 8:415–435. https://doi.org/10.1146/annurev-virology-091919-074551
Rahman MRM, Monir M, Haque M, Siddique M, Khasruzzaman A, Rahman M, Islam M (2021) Isolation and molecular detection of Streptococcus agalactiae from popped eye disease of cultured tilapia and Vietnamese koi fishes in Bangladesh. J Adv Vet Anim Res 8:1. https://doi.org/10.5455/javar.2021.h480
Ramos-Vivas J, Superio J, Galindo-Villegas J, Acosta F (2021) Phage therapy as a focused management strategy in aquaculture. IJMS 22:10436. https://doi.org/10.3390/ijms221910436
Razzak LA, Ambak MA, Hassan M, Sheriff SMD, Nadirah M, Draman AS, Wahab W, Nurhafizah WWI, Alia SA, Jabar A, Najiah M (2017) Molecular identification and histopathological study of natural Streptococcus agalactiae infection in hybrid tilapia (Oreochromisniloticus). Vet World 10:101–111. https://doi.org/10.14202/vetworld.2017.101-111
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor laboratory press, Cold Spring Harbor
Shivu MM, Rajeeva BC, Girisha SK, Karunasagar I, Krohne G, Karunasagar I (2007) Molecular characterization of Vibrio harveyi bacteriophages isolated from aquaculture environments along the coast of India. Environ Microbiol 9:322–331. https://doi.org/10.1111/j.1462-2920.2006.01140.x
Silva YJ, Moreirinha C, Pereira C, Costa L, Rocha RJM, Cunha A, Gomes NCM, Calado R, Almeida A (2016) Biological control of Aeromonas salmonicida infection in juvenile Senegalese sole (Solea senegalensis) with Phage AS-A. Aquac 450:225–233. https://doi.org/10.1016/j.aquaculture.2015.07.025
Soto E, Zayas M, Tobar J, Illanes O, Yount S, Francis S, Dennis MM (2016) Laboratory-controlled challenges of Nile tilapia (Oreochromis niloticus) with Streptococcus agalactiae: comparisons between immersion, oral, intracoelomic and intramuscular routes of infection. J Comp Pathol 155:339–345. https://doi.org/10.1016/j.jcpa.2016.09.003
Stalin N, Srinivasan P (2017) Efficacy of potential phage cocktails against Vibrio harveyi and closely related Vibrio species isolated from shrimp aquaculture environment in the south east coast of India. Vet Microbiol 207:83–96. https://doi.org/10.1016/j.vetmic.2017.06.006
Sumithra TG, Anusree VN, Reshma KJ, Sharma SRK, Suja G, Amala PV, Sayooj P (2019) An outbreak of Streptococcosis in genetically improved farmed tilapia (Oreochromis niloticus L.) reared at a brackish water cage farm of India. Pathological and microbiological characterization: In Aquatic animal health, India: 169
Surekhamol IS (2012) Vibrio harveyi phages: isolation, characterization and evaluation of their potential as phage therapeutics on Vibrio harveyi in shrimp hatcheries, Cochin University of Science and Technology
Tan S, Lin Y, Foo K, Koh HF, Tow C, Zhang Y, Ang LW, Cui L, Badaruddin H, Ooi PL, Lin RTP, Cutter J (2016) Group B Streptococcus serotype III sequence type 283 bacteremia associated with consumption of raw fish, Singapore. Emerg Infect Dis 22:1970–1973. https://doi.org/10.3201/eid2211.160210
Teplow DB, Nakayama C, Leung PC, Harshey RM (1988) Structure-function relationships in the transposition protein B of bacteriophage Mu. J Biol Chem 263:10851–10857. https://doi.org/10.1016/S0021-9258(18)38048-7
Van Belleghem J, Dąbrowska K, Vaneechoutte M, Barr J, Bollyky P (2018) Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses 11:10. https://doi.org/10.3390/v11010010
Vendrell D, Balcazar J, Ruizzarzuela I, Deblas I, Girones O, Muzquiz J (2006) Lactococcus garvieae in fish: a review. Comp Immunol Microbiol Infect Dis 29:177–198. https://doi.org/10.1016/j.cimid.2006.06.003
Wu JL, Lin HM, Jan L, Hsu YL, Chang LH (1981) Biological control of fish bacterial pathogen, Aeromonas hydrophila, by bacteriophage AH 1. Fish Pathol 15:271–276. https://doi.org/10.3147/jsfp.15.271
Zrelovs N, Dislers A, Kazaks A (2020) Motley Crew: Overview of the Currently Available Phage Diversity. Front Microbiol 11:579452. https://doi.org/10.3389/fmicb.2020.579452
Acknowledgements
The authors are grateful to the Kerala University of Fisheries and Ocean Studies (KUFOS) for the financial support to carry out the work. We acknowledge Faculty of Fisheries Science for providing microbiology laboratory facility of the Department of Fish Processing Technology, Kerala University of Fisheries and Ocean Studies (KUFOS). We are grateful to Central Marine Fisheries Research Institute (ICAR-CMFRI) for providing bacterial isolate for this study.
Author information
Authors and Affiliations
Contributions
Rajan Preenanka: investigation, writing—original draft, visualization. Muhammed P Safeena: conceptualization, methodology, validation, writing—reviewing and editing. Rahul Krishnan: validation, writing—reviewing and editing.
Corresponding author
Ethics declarations
Ethical approval
Challenge experiment was performed according to the guidelines of the committee for the purpose of control and supervision of experiments on animals (CPCSEA) registration number 1174/ac/08/CPCSEA. The protocol was reviewed and approved by the institutional animal ethics committee of Kerala University of Fisheries and Ocean Studies (KUFOS), India.
Consent to participate
Not applicable
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Handling Editor: Brian Austin
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Preenanka, R., Safeena, M.P. & Krishnan, R. Evaluation of therapeutic potential of Streptococcus phage-1A against Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus). Aquacult Int 31, 1439–1456 (2023). https://doi.org/10.1007/s10499-022-01036-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10499-022-01036-w